METTL3 increased HK2 and SLC2A1(GLUT1) mRNA stability and transcription levels through an m6A-IGF2BP2/3-dependent mechanism, then activated CRC glucose metabolism to facilitate cell proliferation and tumor growth in vitro and in vivo (34). The gene discussed is IGF2BP2; the disease is colorectal carcinoma.